CARBONI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 3.208
EU - Europa 1.835
AS - Asia 1.090
AF - Africa 84
OC - Oceania 6
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.228
Nazione #
US - Stati Uniti d'America 3.199
GB - Regno Unito 544
CN - Cina 480
IT - Italia 436
SG - Singapore 339
DE - Germania 251
SE - Svezia 133
IN - India 113
VN - Vietnam 101
RU - Federazione Russa 90
UA - Ucraina 89
IE - Irlanda 76
FR - Francia 73
ZA - Sudafrica 54
EE - Estonia 33
BG - Bulgaria 28
ES - Italia 15
GR - Grecia 15
CI - Costa d'Avorio 13
TG - Togo 12
CH - Svizzera 11
ID - Indonesia 10
NL - Olanda 10
FI - Finlandia 9
HK - Hong Kong 8
CA - Canada 7
KR - Corea 7
AU - Australia 6
JO - Giordania 6
JP - Giappone 6
TR - Turchia 6
BE - Belgio 5
CZ - Repubblica Ceca 5
IR - Iran 5
AT - Austria 3
LB - Libano 3
PT - Portogallo 3
RO - Romania 3
BR - Brasile 2
CU - Cuba 2
PL - Polonia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
EC - Ecuador 1
EG - Egitto 1
IL - Israele 1
KZ - Kazakistan 1
MA - Marocco 1
NG - Nigeria 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.228
Città #
Southend 501
Fairfield 495
Singapore 299
Santa Clara 245
Ashburn 242
Woodbridge 231
Wilmington 220
Chandler 212
Seattle 201
Houston 184
Cambridge 160
Princeton 157
Bologna 117
Ann Arbor 100
Boardman 92
Turin 83
Dublin 76
Dong Ket 67
Nanjing 64
Westminster 57
Jacksonville 52
Padova 52
Berlin 38
Beijing 35
Jinan 31
Saint Petersburg 31
Sofia 28
San Diego 26
Mülheim 24
Shenyang 22
Shanghai 21
Milan 20
San Venanzo 18
Changsha 16
Hebei 16
Tianjin 16
Guangzhou 15
Haikou 15
Nanchang 15
Abidjan 13
Los Angeles 13
Medford 13
Dearborn 12
Lomé 12
Zhengzhou 12
Jakarta 10
Jiaxing 10
London 10
Norwalk 10
Wuhan 10
Lanzhou 9
Madrid 9
San Francisco 9
Helsinki 8
Falls Church 7
Hangzhou 7
Modena 7
Shenzhen 7
Amman 6
Cirié 6
Fuzhou 6
Harbin 6
Naples 6
Parma 6
Taiyuan 6
Taizhou 6
Trento 6
Bühl 5
Des Moines 5
Florence 5
Forlì 5
Frankfurt Am Main 5
New York 5
Ningbo 5
Reggio Emilia 5
Brugherio 4
Foshan 4
Frankfurt am Main 4
Kunming 4
Olalla 4
Philadelphia 4
Redmond 4
San Cristóbal de La Laguna 4
Shijiazhuang 4
Tokyo 4
Toronto 4
Xi'an 4
Amsterdam 3
Baoding 3
Bern 3
Brussels 3
Chicago 3
Hong Kong 3
Kendall Park 3
Kowloon 3
Melbourne 3
Moscow 3
Paris 3
Phoenix 3
Wenzhou 3
Totale 4.663
Nome #
Cocaine and ethanol target 26S proteasome activity and gene expression in neuroblastoma cells 148
A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress. 137
Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression 125
Cross-disease analysis of Alzheimer’s disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases 123
Conditioning properties of social subordination in rats: behavioral and biochemical correlates of anxiety. 122
Treatment with the neurotoxic Aβ (25-35) peptide modulates the expression of neuroprotective factors Pin1, Sirtuin 1, and brain-derived neurotrophic factor in SH-SY5Y human neuroblastoma cells 122
Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system 117
Differential behavioral, physiological and hormonal sensitivity to LPS challenge in rats. 114
Opioid gene expression changes and post-translational histone modifications at promoter regions in the rat nucleus accumbens after acute and repeated 3,4-methylenedioxy-methamphetamine (MDMA) exposure 111
Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients 110
Proteome effects of antidepressant medications. 109
Repeated nicotine exposure modulates prodynorphin and pronociceptin levels in the reward pathway 109
Escitalopram affects cytoskeleton and synaptic plasticity pathways in a rat gene-environment interaction model of depression as revealed by proteomics. Part II: environmental challenge. 108
Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies 106
Alteration of behavioral and endocrinological reactivity induced by 3 brief social defeats in rats: Relevance to human psychopathology. 104
Effect of the p38 MAPK inhibitor SB-239063 on Lipopolysaccharide-induced psychomotor retardation and peripheral biomarker alterations in rats. 104
Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours. 103
The contribution of proteomic studies in humans, animal models, and after antidepressant treatments to investigate the molecular neurobiology of major depression 103
Different susceptibility to social defeat stress of BalbC and C57BL6/J mice. 102
Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice 100
Increased expression of CRF and CRF-receptors in dorsal striatum, hippocampus, and prefrontal cortex after the development of nicotine sensitization in rats 99
Proteomic analysis of rat hippocampus after repeated psychosocial stress. 98
Escitalopram modulates neuron-remodelling proteins in a rat gene-environment interaction model of depression as revealed by proteomics. Part I: genetic background. 98
Proteome effects of antipsychotic drugs: Learning from preclinical models 98
Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release. 97
Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stress. 97
p38 MAP kinase activation does not stimulate serotonin transport in rat brain: Implications for sickness behaviour mechanisms 97
Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression 97
Social defeat-induced contextual conditioning differentially imprints behavioral and adrenal reactivity: a time-course study in the rat. 96
Peripheral biomarkers in animal models of major depressive disorder 96
Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation 96
Single exposure to social defeat increases corticotropin-releasing factor and glucocorticoid receptor mRNA expression in rat hippocampus. 95
Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. 95
Proteomics of rat hypothalamus,hippocampus and pre-frontal/frontal cortex after central administration of the neuropeptide PACAP. 94
Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists. 93
Proteomic analysis of rat cortical neurons after fluoxetine treatment. 92
Regulation of cytoskeleton machinery, neurogenesis and energy metabolism pathways in a rat gene-environment model of depression revealed by proteomic analysis. 90
Serum proteomic analysis during nicotine self-administration, extinction and relapse in rats. 88
Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stress. 87
null 86
Strain-specific outcomes of repeated social defeat and chronic fluoxetine treatment in the mouse. 86
Proteomics of Preclinical Models of Depression 84
Serum proteomic analysis during nicotine self-administration, withdrawal, extinction and relapse in rats. 83
Proteomic changes in rat serum, polymorphonuclear and mononuclear leukocytes after chronic nicotine administration 83
Chronic Trazodone and Citalopram Treatments Increase Trophic Factor and Circadian Rhythm Gene Expression in Rat Brain Regions Relevant for Antidepressant Efficacy 82
Systems biology integration of proteomic data in rodent models of depression reveals involvement of the immune response and glutamatergic signaling 82
Nortriptyline influences protein pathways involved in carbohydrate metabolism and actin-related processes in a rat gene-environment model of depression. 82
Global analysis of gene and protein expression in rat models of depression with analysis of gene-environment interaction and antidepressant effects. 80
The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder. 79
Proteome changes in rat hippocampus and pre-frontal/frontal cortex in Flinders rats after Nortriptyline treatment. 79
Altered mrna levels of stress-related peptides in mouse hippocampus and caudate-putamen in withdrawal after long-term intermittent exposure to tobacco smoke or electronic cigarette vapour 79
An Exploratory Pilot Study of Changes in Global DNA Methylation in Patients Undergoing Major Breast Surgery Under Opioid-Based General Anesthesia 79
Proteome changes in rat hippocampus and pre-frontal/frontal cortex in Flinders rats after Escitalopram treatment. 75
The Flinders rat model of depression: gene-environment interaction and antidepressant effects by proteomic analysis. 72
Social defeat-induced contextual conditioning differentially imprints behavioural and adrenal reactivity: a time-course study in the rat. 71
Circadian profile of peripheral hormone levels in Sprague Dawley rats and in common marmosets (Callithrix jaccus). 70
Proteomic analysis of hippocampus and frontal cortex in a rat model of depression with gene-environment interaction and antidepressant treatment. 66
Depression-Associated Gene Negr1-Fgfr2 Pathway Is Altered by Antidepressant Treatment 64
Neuropeptide Y, calcitonin gene-related peptide, and neurokinin A in brain regions of HAB rats correlate with anxiety-like behaviours 56
Persistent cognitive and affective alterations at late withdrawal stages after long-term intermittent exposure to tobacco smoke or electronic cigarette vapour: Behavioural changes and their neurochemical correlates 55
Folate metabolism biomarkers from two randomised placebo-controlled clinical studies with paroxetine and venlafaxine 54
Increased Expression of Autophagy-Related Genes in Alzheimer’s Disease—Type 2 Diabetes Mellitus Comorbidity Models in Cells 51
Single-cell-led drug repurposing for Alzheimer's disease 34
Protein Networks Associated with Native Metabotropic Glutamate 1 Receptors (mGlu1) in the Mouse Cerebellum 34
MicroRNAs Associated with IgLON Cell Adhesion Molecule Expression 33
null 33
Estrogen regulation of prodynorphin gene expression in the rat adenohypophysis: E ffect of the antiestrogen tamoxifen 33
Ca2+ channel blocking activity of lacidipine and amlodipine in A7r5 vascular smooth muscle cells 27
Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses 25
The Role of IgLON Cell Adhesion Molecules in Neurodegenerative Diseases 24
Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo 24
Effects of naloxone on the secretion of atrial natriuretic factor and of noradrenaline during hydric load in moderate chronic heart failure 24
Differential expression of SAPK isoforms in the rat brain. An in situ hybridisation study in the adult rat brain and during post-natal development 24
Prodynorphin mRNA expression in adult cultured rat ventricular cardiac myocytes 24
Agonist binding properties for recombinant kappa opioid receptors expressed in CHO-K1 cells 24
Identification of genes and gene pathways associated with major depressive disorder by integrative brain analysis of rat and human prefrontal cortex transcriptomes 21
Inhibition of proopiomelanocortin translation by an antisense oligodeoxynucleotide 21
Inhibition of proopiomelanocortin expression by an oligodeoxynucleotide complementary to β-endorphin mRNA 20
Endogenous opioid system and atrial natriuretic factor in normotensive offspring of hypertensive parents at rest and during exercise test 18
Prodynorphin mRNA is synthesized in adult cultured rat ventricular cardiomyocytes 18
CCB, a novel specific κ opioid agonist, which discriminates between opioid and σ1 recognition sites 17
Post-transcriptional inhibition of ornithine decarboxylase induction by zinc in a difluoromethylornithine resistant cell line 13
CCB: A novel anologue of MPCB with high binding affinity and specific kappa opioid receptor agonist 13
Zinc is required for the expression of ornithine decarboxylase in a difluoromethylornithine-resistant cell line 12
Quantitative analysis of two-dimensional gel-separated proteins using isotopically marked alkylating agents and matrix-assisted laser desorption/ionization mass spectrometry 12
Molecular mechanisms of the positive reinforcing effect of nicotine 12
Synthesis of (+)-(1'R,2'S) and (1'S,2'R)-6,11-Dimethyl-1,2,3,4,5,6- hexahydro-3-[[2'-(alkoxycarbonyl)-2'-phenylcyclopropyl]methyl]-2,6-methano- 3-benzazocin-8-ol. Comparison of the affinities for σ1 and opioid receptors with in the diastereoisomeric MPCB and CCB 11
Social defeat-induced contextual conditioning differentially imprints behavioral and adrenal reactivity: A time-course study in the rat 11
Localization of the messenger RNA for the c-Jun NH2-terminal kinase kinase in the adult and developing rat brain: An in situ hybridization study 9
Proteomic analysis of rat brain tissue: Comparison of protocols for two-dimensional gel electrophoresis analysis based on different solubilizing agents 9
Anxiety-Like Behaviors and Neuropeptide Y, Tachykinins and Beyond 8
Proteomics in drug research 8
Totale 6.374
Categoria #
all - tutte 18.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.218 0 0 0 0 0 198 234 243 237 106 66 134
2020/2021693 185 54 30 51 2 15 22 34 86 25 20 169
2021/2022947 72 29 62 39 115 44 36 103 32 30 212 173
2022/20231.022 153 114 36 100 60 59 51 61 162 49 142 35
2023/2024360 28 49 31 35 29 56 34 22 13 27 13 23
2024/20251.103 82 236 242 65 416 62 0 0 0 0 0 0
Totale 6.374